Chordate Medical Holding AB (publ) (STO:CMH)

Market Cap	18.95M
Revenue (ttm)	2.41M
Net Income (ttm)	-26.99M
Shares Out	2.70M
EPS (ttm)	-20.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,265
Average Volume	24,331
Open	6.46
Previous Close	6.50
Day's Range	6.40 - 7.02
52-Week Range	4.99 - 48.00
Beta	1.65
RSI	51.69
Earnings Date	Aug 29, 2025

About STO:CMH

Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for neurostimulation treatment in Sweden. It offers Ozilia, a neuromodulation and medication-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 3
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: CMH

Financial Performance

In 2024, STO:CMH's revenue was 2.44 million, an increase of 39.85% compared to the previous year's 1.75 million. Losses were -27.25 million, -6.62% less than in 2023.